Your session is about to expire
← Back to Search
Building Infrastructure for Community Capacity in Accelerating Integrated Care
N/A
Waitlist Available
Led By Margarita Alegria, Ph.D.
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 3 months, 6 months, and 12 months after baseline
Awards & highlights
No Placebo-Only Group
Summary
This trial tests the STRONG MINDS model, which uses community health workers to support low-income racial/ethnic and linguistic minority adults with moderate to severe depression or anxiety. The goal is to improve their mental health by providing culturally appropriate care in their language.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, 3 months, 6 months, and 12 months after baseline
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 3 months, 6 months, and 12 months after baseline
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Engagement in MH (change)
Functioning: WHODAS 2.0 (change)
Hopkins Symptoms Checklist-25 (change)
+1 moreSecondary study objectives
CAT-MH (including CAT-SA for substance) (change)
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: Strong Minds ProgramExperimental Treatment1 Intervention
This is a 10-session, culturally-adapted intervention, that includes cognitive behavioral therapy techniques combined with mindfulness exercises, led by a Community Health Worker.
Group II: Enhanced Usual CareExperimental Treatment1 Intervention
Enhanced usual care includes check in calls by a Care Manager 4 times over the course of 6 months and educational materials about depression and anxiety.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Strong Minds
2019
N/A
~1050
Find a Location
Who is running the clinical trial?
Massachusetts General HospitalLead Sponsor
3,023 Previous Clinical Trials
13,316,905 Total Patients Enrolled
1 Trials studying Mental Health
886 Patients Enrolled for Mental Health
University of North Carolina, GreensboroOTHER
32 Previous Clinical Trials
15,677 Total Patients Enrolled
1 Trials studying Mental Health
18 Patients Enrolled for Mental Health
Margarita Alegria, Ph.D.Principal Investigator - Massachusetts General Hospital
Massachusetts General Hospital
3 Previous Clinical Trials
1,098 Total Patients Enrolled
Gabriela Livas Stein, Ph.D.Principal InvestigatorUniversity of North Carolina, Greensboro